Neural Regeneration Research ›› 2019, Vol. 14 ›› Issue (9): 1519-1521.doi: 10.4103/1673-5374.255968

Previous Articles     Next Articles

Neuroprotective effect of NeuroEPO in neurodegenerative disease: “Alea jacta est”

Ramón Rama 1, Fernando Garzón 2, Yamila Rodríguez-Cruz 3, Tangui Maurice 4, Julio-César García-Rodríguez 5   

  1. 1 Department Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain;
    2 Department of Animal Health, University of Nariño, Pasto, Nariño, Colombia;
    3 Department of Histology, University of Medical Sciences, Havana, Cuba;
    4 MMDN, Univ Montpellier, INSERM, EPHE, UMR_S1198, Montpellier, France;
    5 CENPALAB, National Center for Animals Breeding, Havana, Cuba
  • Online:2019-09-15 Published:2019-09-15
  • Contact: Ramón Rama, PhD, rrama@ub.edu.

Abstract:

Our common home, planet Earth, is inhabited by more than 7 billion human beings. The average life expectancy currently estimated for men is ~69 years, with strong differences among countries. Currently, neurodegenerative diseases are currently the leading cause of death and disability worldwide. In clinical use and neuroscience research, a solution for an effective diagnosis is in progress, but a prophylactic treatment to counteract this long-lasting plague for humanity is still unidentified.

CLC Number: